[Severe rachitic osteopathy during long-term anticonvulsant treatment].
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D002118:Calcium / Q000097:blood; D002220:Carbamazepine / Q000009:adverse effects; D002648:Child; D002762:Cholecalciferol / Q000008:administration & dosage; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D006801:Humans; D007085:Ilium / Q000473:pathology; D007501:Iron / Q000008:administration & dosage; D008134:Long-Term Care; D008297:Male; D010018:Osteomalacia / Q000139:chemically induced; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D010758:Phosphorus / Q000097:blood; D011324:Primidone / Q000009:adverse effects; D012279:Rickets / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D000927:Anticonvulsants; D011324:Primidone; D002762:Cholecalciferol; D010758:Phosphorus; D002220:Carbamazepine; D010672:Phenytoin; D007501:Iron; D000469:Alkaline Phosphatase; D002118:Calcium; D010634:Phenobarbital
Schwere rachitische Osteopathie bei antiepileptischer Langzeitbehandlung.